Steve Swenson

Dr. Steve Swenson is Assistant Professor of Research in Neurological Surgery, focusing on developing protein-based therapeutics for cancer treatment. His research explores disintegrin proteins derived from snake venoms as targeted anti-angiogenic and anti-metastatic agents. Current projects include optimizing tumor-targeting conjugates for glioblastoma therapy and developing molecular imaging probes for cancer detection.

His investigations into contortrostatin demonstrated inhibition of tumor growth and metastasis in breast cancer models. Recent work engineers novel conjugates like NEO212 that cross the blood-brain barrier to target glioblastoma stem cells, showing promising preclinical results in inhibiting tumor migration and invasion pathways.

Dr. Swenson's translational research bridges biochemistry and clinical oncology, with publications demonstrating consistent focus on tumor microenvironment modulation. Studies combine molecular characterization of therapeutic agents with efficacy validation across multiple cancer models.